Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A 46-Year Study Traces the Lupus Death Rate from 1968–2013

Kurt Ullman  |  Issue: September 2018  |  September 20, 2018

Dr. Bartow

Dr. Bartow

Thomas Bartow, MD, FACP, is clinical lead in rheumatology at the Marshfield Clinic Health System in Marshfield, Wis. He notes the study was well done for the question it asked.

“This study is a very imaginative way to ask the very basic question of whether we are doing better in keeping SLE patients alive,” says Dr. Bartow, who was not involved in the study. “It is a very fundamental question to ask, and I think they went about getting their answer in a very ambitious way, going all the way back to 1968.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although he notes the increase in deaths from 1975–1999, he thinks this may be less of an indicator of treatment and more of an indicator of case finding. He points out that the time of the bump in death rates was about the time improvements in lab testing began impacting diagnosis. These advances may also explain the lowering of death rates from 1999 forward.

“From the clinician’s viewpoint, it is [now] much easier to diagnose lupus earlier, and this means we are seeing patients with much milder disease than before, but on the other hand, we are seeing more of them,” Dr. Bartow says. “The encouraging thing is, we are doing better. The death rate is going down, so I think we are on the right track.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Kurt Ullman has been a freelance writer for more than 30 years and a contributing writer to The Rheumatologist for 10 years.

Reference

  1. Yen EY, Shaheen M, Woo JMP, et al. 46-Year trends in systemic lupus erythematosus mortality in the United States, 1968 to 2013: A nationwide population-based study. Ann Intern Med. 2017 Dec 5;167(11):777–785.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:death ratelower death ratesmortality rate

Related Articles

    Lupus Survival Is Improving Slowly

    October 30, 2017

    NEW YORK (Reuters Health)—Systemic lupus erythematosus (SLE) mortality has declined during the past 46 years in the U.S.—but more slowly than mortality in the general population, according to a nationwide study. “Based on our experience in the clinic and according to previous reports showing improvement in the short-term (five- to 10-year) survival in lupus, I…

    Study Reveals Lupus Is a Leading Cause of Death in U.S. Women

    October 18, 2018

    Systemic lupus erythematosus (SLE) is a leading cause of death among young women, according to an August 2018 study in Arthritis & Rheumatology.1 To help determine where SLE ranks among causes of death, Eric Y. Yen, MD, and Ram Raj Singh, MD, conducted a population-based study using nationwide mortality counts for all female residents of…

    Studies Highlight Risk of Damage from Lupus Treatments

    April 20, 2017

    WASHINGTON, D.C.—Conference goers who braved the final day of the 2016 ACR/ARHP Annual Meeting were awarded for their stamina by learning about issues relating to the damage caused by systemic lupus erythematosus (SLE) during the session Systemic Lupus Erythematosus—Clinical Aspects and Treatment V: Damage and Morbidity. Minimizing Damage: Early Use of GC-Sparing Strategies Jayne Little,…

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences